Sfmg, LLC Vertex Pharmaceuticals Inc Transaction History

Sfmg, LLC

$1.14 Billion
Q2 2024

A detailed history of Sfmg, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sfmg, LLC holds 7,845 shares of VRTX stock, worth $3.94 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

7,845

Previous 7,785 0.77%

Holding current value

$3.94 Million

Previous $3.25 Million 13.0%

% of portfolio

0.32%

Previous 0.28%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $23,568 - $29,131	60 Added 0.77%	7,845 $3.68 Million
Q1 2024 May 07, 2024	BUY	$407.69 - $446.08 $26,092 - $28,549	64 Added 0.83%	7,785 $3.25 Million
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $336,826 - $403,287	982 Added 14.57%	7,721 $3.14 Million
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $666,214 - $714,046	-1,970 Reduced 22.62%	6,739 $2.34 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $6,602 - $7,390	-21 Reduced 0.24%	8,709 $3.06 Million
Q1 2023 May 01, 2023	BUY	$283.23 - $323.1 $4,248 - $4,846	15 Added 0.17%	8,730 $2.75 Million
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $45,347 - $56,462	-193 Reduced 2.17%	8,715 $2.46 Million
Q1 2022 Apr 21, 2022	SELL	$221.42 - $260.97 $15,942 - $18,789	-72 Reduced 0.8%	8,908 $2.33 Million
Q4 2021 Jan 31, 2022	BUY	$177.01 - $223.45 $189,400 - $239,091	1,070 Added 13.53%	8,980 $1.97 Million
Q3 2021 Nov 01, 2021	SELL	$181.39 - $202.99 $19,952 - $22,328	-110 Reduced 1.37%	7,910 $1.44 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $365,605 - $431,145	1,950 Added 32.13%	8,020 $1.62 Million
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $244,283 - $284,745	1,180 Added 24.13%	6,070 $1.3 Million
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $1.01 Million - $1.35 Million	4,890 New	4,890 $1.16 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.

Account